Related Experiment Video
Updated: Jun 17, 2026
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
A High-Affinity NIR Fluorescent Probe for Aβ Oligomers Enables Theranostics Through Disrupting Membrane Interaction
Min Yang1, Yuhan Wang1, Jianhua Deng1
1School of Engineering, China Pharmaceutical University, Nanjing 210009, China.
None:
Amyloid-β (Aβ) oligomers serve as pivotal biomarkers and therapeutic targets in Alzheimer's disease (AD) due to their early emergence in pathogenesis and high level of neurotoxicity. In this work, we introduce a class of D-π-A amphiphilic fluorescent probes engineered for simultaneous detection and therapeutic modulation of Aβ oligomers. The lead compound, API-QB, exhibits a near-infrared (NIR) wavelength upon interaction with Aβ oligomers and demonstrates high selectivity and sensitivity toward Aβ oligomers in both solution and simulated brain environments. Importantly, API-QB is able to inhibit Aβ aggregation by interacting with oligomers. Furthermore, probe API-QB can reduce the toxicity of Aβ oligomers by inhibiting the interaction between oligomers and cell membranes and suppressing the production of reactive oxygen species generated by Aβ oligomers. Therefore, probe API-QB, which features NIR emission at 720 nm, a Kd of 6.38 nM, and a 47-fold fluorescence enhancement upon binding to Aβ oligomers, represents an attractive multifunctional candidate for integrated diagnostic imaging and therapeutic intervention in AD.
